SCHEMBL7418110

SCHEMBL7418110

CCCc1[nH]c2cc(C(=O)OC)ccc2c1C(=O)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.58
MEN1 O00255 4/20 0.58
ATM Q13315 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
KIF11 P52732 1/20 0.55
PARP1 P09874 2/20 0.52
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.45
PDGFRB P09619 4/20 0.45
KDR P35968 5/20 0.44
FGFR1 P11362 4/20 0.44
FLT1 P17948 4/20 0.44
FGFR3 P22607 4/20 0.44
PDGFRA P16234 3/20 0.44
KDM4E B2RXH2 1/20 0.43
GLA P06280 1/20 0.43
GAA P10253 1/20 0.43
PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7423432 0.86 KMT2A (0.62) KMT2AMEN1ATML3MBTL1KIF11
SCHEMBL8557670 0.85 KMT2A (0.53) KMT2AMEN1ATML3MBTL1KIF11
SCHEMBL7419842 0.85 KMT2A (0.60) KMT2AMEN1ATML3MBTL1KIF11
SCHEMBL7419290 0.83 KMT2A (0.58) KMT2AMEN1ATML3MBTL1KIF11
SCHEMBL7422800 0.83 KMT2A (0.58) KMT2AMEN1ATML3MBTL1KIF11
SCHEMBL7423340 0.83 KMT2A (0.55) KMT2AMEN1ATML3MBTL1KIF11
SCHEMBL7476488 0.82 KMT2A (0.57) KMT2AMEN1ATML3MBTL1KIF11
SCHEMBL7409075 0.81 KMT2A (0.55) KMT2AMEN1ATML3MBTL1KIF11
SCHEMBL7421320 0.81 KMT2A (0.56) KMT2AMEN1ATML3MBTL1KIF11
SCHEMBL7418380 0.81 KMT2A (0.56) KMT2AMEN1ATML3MBTL1KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed